Asian Pacific Journal of Cancer Prevention

1. Promoter Hypermethylation of LATS2 Gene in Oral Squamous Cell Carcinoma (OSCC) Among North Indian Population.

Volume 21, Issue 5, May 2020, Pages 1283-1287

Harsh Goel; Saloni Singhal; Runjhun Mathur; Saima Syeda; Rishi Kumar Gupta; Anshuman Kumar; Anju Shrivastava; Abhimanyu Kumar Jha

2. Can the Irisin be a Biomarker for Prostate Cancer? A Case Control Study

Volume 21, Issue 2, February 2020, Pages 505-509

Rahmi Aslan; Hamit Hakan Alp; Recep Eryılmaz; Zubeyir Huyut; Mehmet Sevim; Şeyhmuz Araz; Kasim Ertas; Kerem Taken

3. Dynamic Changes of Circulating Mir-155 Expression and the Potential Application as a Non-Invasive Biomarker in Breast Cancer

Volume 21, Issue 2, February 2020, Pages 491-497

Sumadi Lukman Anwar; Dewi Sahfitri Tanjung; Meutia Srikandi Fitria; Aprilia Indra Kartika; Dwi Nur Indah Sari; Dinna Rakhmina; Tirta Wardana; Indwiani Astuti; Sofia Mubarika Haryana; Teguh Aryandono

4. Salivary MMP-9 as a Biomarker for the Diagnosis of Oral Potentially Malignant Disorders and Oral Squamous Cell Carcinoma

Volume 21, Issue 1, January 2020, Pages 233-238

Komal Smriti; Meenakshi Ray; Tilottama Chatterjee; Revathi-Panduranga Shenoy; Srikanth Gadicherla; Kalyana-Chakravarthy Pentapati; Nasrullah Rustaqi

5. Exosomes as a Surrogate Marker for Autophagy in Peripheral Blood, Correlative Data from Phase I Study of Chloroquine in Combination with Carboplatin/Gemcitabine in Advanced Solid Tumors

Volume 20, Issue 12, December 2019, Pages 3789-3796

Nagla Abdel Karim; Ola Gaber; Ihab Eldessouki; El Mustapha Bahassi; John Morris

6. Aberrant Promoter Hypermethylation of RASSF1a and BRCA1 in Circulating Cell-Free Tumor DNA Serves as a Biomarker of Ovarian Carcinoma

Volume 20, Issue 10, October 2019, Pages 3001-3005

Sandeep Kumar S; Shalini N Swamy; C S Premalatha; V R Pallavi; Ramesh Gawari

7. High Resolution Based Quantitative Determination of Methylation Status of CDH1 and VIM Gene in Epithelial Ovarian Cancer

Volume 20, Issue 10, October 2019, Pages 2923-2928

Gaurav Kr Thakur; Tusha Sharma; T Krishna Latha; B D Banerjee; Harendra Kr Shah; Kiran Guleria

8. Reduced Expression of IL-1β and IL-18 Proinflammatory Interleukins Increases the Risk of Developing Cervical Cancer

Volume 20, Issue 9, September 2019, Pages 2715-2721

Jose Anibal Matamoros; Maria Isabel Ferreira da Silva; Patrícia Muniz Mendes Freire de Moura; Maria da Conceição Gomes Leitão; Eliane Campos Coimbra

9. Circulating miR-34a and miR-125b as Promising non Invasive Biomarkers in Egyptian Locally Advanced Breast Cancer Patients

Volume 20, Issue 9, September 2019, Pages 2749-2755

Neemat M Kassem; Wael S Makar; Hebatallah A Kassem; Soha Talima; Mustafa Tarek; Hadeer Hesham; Mohamed A El-Desouky

10. Three Markers in Cancerous and Healthy Cells of Patients with Non-Small-Cell Lung Carcinoma (NSCLC)

Volume 20, Issue 8, August 2019, Pages 2281-2285

Hamidreza Jamaati; Adnan Khosravi; Atefeh Abedini; Arda Kiani; Payam Tabarsi; Hossein Dargahi; Naghmeh Bahrami; Mehdi Kazempour Dizaji; Farahnaz Sadegh Beigee; Mihan Pourabdollah; Abbas Gheysouri; Nasser Ahmadian; Masoum Abniki; Abdolreza Mohamadnia; Aliakbar Velayati

11. Salivary Tumour Necrosis Factor-α as a Biomarker in Oral Leukoplakia and Oral Squamous Cell Carcinoma

Volume 20, Issue 7, July 2019, Pages 2087-2093

Deepthi G; S R K Nandan; Pavan G Kulkarni

12. Assessment of Circulating miRNA-17 and miRNA-222 Expression Profiles as Non-Invasive Biomarkers in Egyptian Patients with Non-Small-Cell Lung Cancer

Volume 20, Issue 6, June 2019, Pages 1927-1933

Helal F Hetta; Asmaa M Zahran; Reham I El-Mahdy; Emad Eldin Nabil; Hend M Esmaeel; Ola A Elkady; Azza Elkady; Dina A Mohareb; Mohammed Mahmoud Mostafa; James John

13. Plasma Level of MicroRNAs, MiR-107, MiR-194 and MiR-210 as Potential Biomarkers for Diagnosis Intestinal-Type Gastric Cancer in Human

Volume 20, Issue 5, May 2019, Pages 1421-1426

Pegah Parvaee; Hossein Sarmadian; Behzad Khansarinejad; Mahmood Amini; Mahdieh Mondanizadeh

14. Upregulation of Circulating MiR-21 Expression as a Potential Biomarker for Therapeutic Monitoring and Clinical Outcome in Breast Cancer

Volume 20, Issue 4, April 2019, Pages 1223-1228

Sumadi Lukman Anwar; Dwi Nur Indah Sari; Aprilia Indra Kartika; Meutia Srikandi Fitria; Dewi Sahfitri Tanjung; Dinna Rakhmina; Tirta Wardana; Indwiani Astuti; Sofia Mubarika Haryana; Teguh Aryandono

15. Clinical Significance of Circulatory miRNA-21 as an Efficient Non-Invasive Biomarker for the Screening of Lung Cancer Patients

Volume 19, Issue 9, September 2018, Pages 2607-2611

F M Abu-Duhier; Jamsheed Javid; M A Sughayer; Rashid Mir; Tariq Albalawi; M Shahid Alauddin

Journal Archive

Volume 21 (2020)

Volume 20 (2019)

Volume 19 (2018)

Volume 18 (2017)

Volume 17 (2016)

Volume 16 (2015)

Volume 15 (2014)

Volume 14 (2013)

Volume 13 (2012)

Volume 12 (2011)

Volume 11 (2010)

Volume 10 (2009)

Volume 9 (2008)

Volume 8 (2007)

Volume 7 (2006)

Volume 6 (2005)

Volume 5 (2004)

Volume 4 (2003)

Volume 3 (2002)

Volume 2 (2001)

Volume 1 (2000)

1. Promoter Hypermethylation of LATS2 Gene in Oral Squamous Cell Carcinoma (OSCC) Among North Indian Population.

2. Can the Irisin be a Biomarker for Prostate Cancer? A Case Control Study

3. Dynamic Changes of Circulating Mir-155 Expression and the Potential Application as a Non-Invasive Biomarker in Breast Cancer

4. Salivary MMP-9 as a Biomarker for the Diagnosis of Oral Potentially Malignant Disorders and Oral Squamous Cell Carcinoma

5. Exosomes as a Surrogate Marker for Autophagy in Peripheral Blood, Correlative Data from Phase I Study of Chloroquine in Combination with Carboplatin/Gemcitabine in Advanced Solid Tumors

6. Aberrant Promoter Hypermethylation of RASSF1a and BRCA1 in Circulating Cell-Free Tumor DNA Serves as a Biomarker of Ovarian Carcinoma

7. High Resolution Based Quantitative Determination of Methylation Status of CDH1 and VIM Gene in Epithelial Ovarian Cancer

8. Reduced Expression of IL-1β and IL-18 Proinflammatory Interleukins Increases the Risk of Developing Cervical Cancer

9. Circulating miR-34a and miR-125b as Promising non Invasive Biomarkers in Egyptian Locally Advanced Breast Cancer Patients

10. Three Markers in Cancerous and Healthy Cells of Patients with Non-Small-Cell Lung Carcinoma (NSCLC)

11. Salivary Tumour Necrosis Factor-α as a Biomarker in Oral Leukoplakia and Oral Squamous Cell Carcinoma

12. Assessment of Circulating miRNA-17 and miRNA-222 Expression Profiles as Non-Invasive Biomarkers in Egyptian Patients with Non-Small-Cell Lung Cancer

13. Plasma Level of MicroRNAs, MiR-107, MiR-194 and MiR-210 as Potential Biomarkers for Diagnosis Intestinal-Type Gastric Cancer in Human

14. Upregulation of Circulating MiR-21 Expression as a Potential Biomarker for Therapeutic Monitoring and Clinical Outcome in Breast Cancer

15. Clinical Significance of Circulatory miRNA-21 as an Efficient Non-Invasive Biomarker for the Screening of Lung Cancer Patients

16. Precision in Oncology; a Future Prospect

17. Protein-Protein Interaction Network Analysis of Salivary Proteomic Data in Oral Cancer Cases

18. Prognostic Value of FBXO39 and ETS-1 but not BMI-1 in Iranian Colorectal Cancer Patients

19. Candidate Biomarkers for Oral Squamous Cell Carcinoma: Differential Expression of Oxidative Stress-Related Genes

20. Analysis of the Lipid Profile in Patients with Colorectal Cancer in Advanced Stages

21. AKAP4, SPAG9 and NY-ESO-1 in Iranian Colorectal Cancer Patients as Probable Diagnostic and Prognostic Biomarkers

22. Expression of Radioresistant Gene PEG10 in OSCC Patients and Its Prognostic Significance

23. Genetic Abnormalities in Oral Leukoplakia and Oral Cancer Progression

24. MicroRNAs and Lymph Node Metastasis in Papillary Thyroid Cancers

25. Involvement of CELSR3 Hypermethylation in Primary Oral Squamous Cell Carcinoma

Journal Archive